Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
27 drugs in development
By Therapeutic Area
top 6
R&D Momentum
99/100
Pipeline Velocity
88/100
Trial Completion Rate
99/100
Pipeline Concentration
24/100
Pipeline Freshness
74/100
Strategic Signals
Activity
Last 14 days
Comparative Study Between Voice Therapy in Reactive Benign Vocal Fold Polyp and Injection of Steroid
Opioid Free Anesthesia Combined With Pectoral Nerve Block (PECS Block) in Breast Cancer Surgery: A Prospective Randomized Study
Comparative Evaluation of Regenerative Potential of Four Different Biological Scaffolds in Treatment of Non Vital Immature Permanent Maxillary Incisors (A Randomized Controlled Clinical Trial)
Short Term Outcomes of Endoscopic Extended Totally Extraperitoneal Repair for Primary Small Sized Midline Ventral Hernia
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone in Management of Atopic Dermatitis in Children
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Combination of Atorvastatin and Mesalazine to Enhance Anti-inflammatory Effects and Attenuates Progression of Ulcerative Colitis
Comparative Study of The Efficacy and Safety of Combined Subcision With Exosomes Injection Versus Subcision Alone in Treatment of Atrophic Post- Acne Scars
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Adjunctive N-Acetylcysteine in the Management of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis: A Randomized Controlled Trial
Clinical Study to Compare the Possible Efficacy of Metformin in Patients With Ulcerative Colitis Treated With Mesalamine
Evaluation of Nitazoxanide as Adjunctive Therapy for Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis: A Randomized Controlled Clinical Trial Protocol
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)